Daidzein alleviates osteoporosis by promoting osteogenesis and angiogenesis coupling
PeerJ · 2023
DOI: 10.7717/peerj.16121 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Junjie Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopaedics and Traumatology, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Osteogenesis, Osteoporosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, Guangdong Basic and Applied Research Foundation, President Foundation of Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
Background
Postmenopausal osteoporosis and osteoporosis-related fractures are world-wide serious public health problem. Recent studies demonstrated that inhibiting caveolin-1 leads to osteoclastogenesis suppression and protection against OVX-induced osteoporosis. This study aimed to explore the mechanism of caveolin-1 mediating bone loss and the potential therapeutic target.
Methods
Thirty C57BL/6 female mice were allocated randomly into three groups: sham or bilateral ovariectomy (OVX) surgeries were performed for mice and subsequently daidzein or vehicle was administrated to animals (control, OVX + vehicle and OVX + daidzein). After 8-week administration, femurs were harvested for Micro-CT scan, histological staining including H&E, immunohistochemistry, immunofluorescence, TRAP. Bone marrow endothelial cells (BMECs) were cultured and treated with inhibitors of caveolin-1 (daidzein) or EGFR (erlotinib) and then scratch wound healing and ki67 assays were performed. In addition, cells were harvested for western blot and PCR analysis.
Results
Micro-CT showed inhibiting caveolin-1with daidzein alleviated OVX-induced osteoporosis and osteogenesis suppression. Further investigations revealed H-type vessels in cancellous bone were decreased in OVX-induced mice, which can be alleviated by daidzein. It was subsequently proved that daidzein improved migration and proliferation of BMECs hence improved H-type vessels formation through inhibiting caveolin-1, which suppressed EGFR/AKT/PI3K signaling in BMECs.
Conclusions
This study demonstrated that daidzein alleviates OVX-induced osteoporosis by promoting H-type vessels formation in cancellous bone, which then promotes bone formation. Activating EGFR/AKT/PI3K signaling could be the critical reason.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Orthopaedics and Traumatology, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Guangdong Provincial Key Laboratory of Bone and Cartilage Regenerative Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Orthopaedics, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, China.
Förderung
- The National Natural Science Foundation of China
- Guangdong Basic and Applied Research Foundation
- President Foundation of Nanfang Hospital, Southern Medical University
Zitieren
APA
Jia, J., He, R., Yao, Z., Su, J., Deng, S., Chen, K., & Yu, B. (2023). Daidzein alleviates osteoporosis by promoting osteogenesis and angiogenesis coupling. PeerJ. https://doi.org/10.7717/peerj.16121
Vancouver
Jia J, He R, Yao Z, Su J, Deng S, Chen K, et al. Daidzein alleviates osteoporosis by promoting osteogenesis and angiogenesis coupling. PeerJ. 2023. doi:10.7717/peerj.16121
BibTeX
@article{Jia2023,
author = {Jia, Junjie and He, Ruiyi and Yao, Zilong and Su, Jianwen and Deng, Songyun and Chen, Kun and Yu, Bin},
title = {Daidzein alleviates osteoporosis by promoting osteogenesis and angiogenesis coupling},
journal = {PeerJ},
year = {2023},
doi = {10.7717/peerj.16121}
}
EUVIMED